about
Accessing biological actions of Ganoderma secondary metabolites by in silico profilingProspective performance evaluation of selected common virtual screening tools. Case study: Cyclooxygenase (COX) 1 and 2.μ Opioid receptor: novel antagonists and structural modeling.Optimized Virtual Screening Workflow for the Identification of Novel G-Quadruplex Ligands.Pharmacophore modeling for COX-1 and -2 inhibitors with LigandScout in comparison to Discovery Studio.Interference of Paraben Compounds with Estrogen Metabolism by Inhibition of 17β-Hydroxysteroid Dehydrogenases.Combining Mutational Signatures, Clonal Fitness, and Drug Affinity to Define Drug-Specific Resistance Mutations in CancerOlanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogeneticsModulating FOXO3 transcriptional activity by small, DBD-binding molecules
P50
Q28829917-DF108497-A2C4-42E6-8780-C67C327188FAQ35615893-2301EA3A-CCE3-429D-9325-4EF7C4475E9FQ38541351-012FFF3C-6944-4488-8E64-CE2D102AF271Q38912565-85DAC908-0136-4978-9579-536574CD826CQ39077950-F354CB14-FCA5-4BE7-A1D8-255A781ABF80Q41660311-8E26C6F0-962E-4225-BE59-E61212BB4FBCQ59125278-6E755562-0B90-4E95-BF85-0218A5399F3FQ64106645-5188B4DB-AEFD-4F56-AC14-151998ED6A8BQ83225642-2430A70B-0C91-4ADE-A835-A7A2590A5301
P50
description
Forscher
@de
chercheur
@fr
hulumtuese
@sq
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Teresa Kaserer
@ast
Teresa Kaserer
@en
Teresa Kaserer
@es
Teresa Kaserer
@nl
type
label
Teresa Kaserer
@ast
Teresa Kaserer
@en
Teresa Kaserer
@es
Teresa Kaserer
@nl
prefLabel
Teresa Kaserer
@ast
Teresa Kaserer
@en
Teresa Kaserer
@es
Teresa Kaserer
@nl
P21
P31
P496
0000-0003-0372-1885